Treatment of Iron Overload Requiring Chelation Therapy
Status:
Withdrawn
Trial end date:
2015-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this open-label study is to assess liver iron concentration using MRI imaging
in subjects with beta-thalassemia when administered with either SPD602 or deferasirox for the
treatment of chronic transfusional iron overload.